SEYED EBRAHIM KASSAIAN to Sirolimus
This is a "connection" page, showing publications SEYED EBRAHIM KASSAIAN has written about Sirolimus.
Connection Strength
0.609
-
Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study. Tex Heart Inst J. 2016 Apr; 43(2):126-30.
Score: 0.418
-
Comparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry. Ther Adv Cardiovasc Dis. 2016 Aug; 10(4):206-13.
Score: 0.104
-
In-hospital and mid-term clinical outcomes after percutaneous coronary intervention with the use of sirolimus- or paclitaxel-eluting stents. Kardiol Pol. 2009 Dec; 67(12):1344-50.
Score: 0.067
-
On-label and off-label use of drug-eluting stents: comparison of short- and long-term outcomes. Tex Heart Inst J. 2012; 39(1):24-9.
Score: 0.019